Tianjin Zhongxin Pharmaceutical Group Corp Ltd (TIAN)

Singapore
Currency in USD
2.350
-0.010(-0.42%)
Delayed Data·
TIAN Scorecard
Full Analysis
Has raised its dividend for 3 consecutive years
High dividend Yield
Fair Value
Day's Range
2.3502.350
52 wk Range
1.9902.660
Key Statistics
Edit
Bid/Ask
2.34 / 2.35
Prev. Close
2.36
Open
2.35
Day's Range
2.35-2.35
52 wk Range
1.99-2.66
Volume
3.4K
Average Volume (3m)
144.31K
1-Year Change
-0.84%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TIAN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory
Show more

Tianjin Zhongxin Pharmaceutical Group Corp Ltd Company Profile

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People’s Republic of China. The company manufactures and sells of biochemical pharmaceutical products. It also engages in research and development of chinese patent medicines, chemical raw materials and preparations, and nutritional supplements. In addition, the company is involved in pharmaceutical and drug retail business. Further, it offers Suxiao Jiuxin pills, Qingyan drop pills, Jingwanhong ointment, Angong Niuhuang pills, Qingfei pills, anti-inflammatory pills, Qinggong Shoutao pills, Biqi capsules, Niuhuang Qingxin pills, Tongmai Yangxin pills, and Weichang An pills. Additionally, the company pharmaceutical logistic services. Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. The company was founded in 1981 and is based in Tianjin, the People’s Republic of China.

Employees
4619
Market
Singapore

Compare TIAN to Peers and Sector

Metrics to compare
TIAN
Peers
Sector
Relationship
P/E Ratio
9.8x24.8x−0.5x
PEG Ratio
0.080.020.00
Price/Book
2.7x2.9x2.6x
Price / LTM Sales
3.3x3.5x3.0x
Upside (Analyst Target)
-17.9%52.7%
Fair Value Upside
Unlock−0.8%7.6%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.89%
Dividend Yield
6.79%
Industry Median 6.09%
Annualised payout
0.16
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Apr 30, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the Tianjin Zhongxin Pharma Group (TIAN) Stock Price Today?

The Tianjin Zhongxin Pharma Group stock price today is 2.35

What Stock Exchange Does Tianjin Zhongxin Pharma Group Trade On?

Tianjin Zhongxin Pharma Group is listed and trades on the Singapore Stock Exchange stock exchange.

What Is the Stock Symbol for Tianjin Zhongxin Pharma Group?

The stock symbol for Tianjin Zhongxin Pharma Group is "TIAN."

Does Tianjin Zhongxin Pharma Group Pay Dividends? What’s The Current Dividend Yield?

The Tianjin Zhongxin Pharma Group dividend yield is 6.68%.

What Is the Tianjin Zhongxin Pharma Group Market Cap?

As of today, Tianjin Zhongxin Pharma Group market cap is 3.02B.

What Is Tianjin Zhongxin Pharma Group's Earnings Per Share (TTM)?

The Tianjin Zhongxin Pharma Group EPS (TTM) is 2.89.

When Is the Next Tianjin Zhongxin Pharma Group Earnings Date?

Tianjin Zhongxin Pharma Group will release its next earnings report on 12 Aug 2025.

From a Technical Analysis Perspective, Is TIAN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.